Market Currents
More on Aastrom Biosciences (ASTM): Q4 beats but losses more than double Y/Y, primarily due to...
-
Monday, March 18, 5:20 PM ETMore on Aastrom Biosciences (ASTM): Q4 beats but losses more than double Y/Y, primarily due to charges and an increases in R&D expenses.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
